论文部分内容阅读
本文收集手术切除的原发性肝癌195例,随访1、3、5、10年生存率分别为60.2％、28.7％、22.9％、12.5％。切除率为34％。16例在术后20天内死亡(8.2％)。女性AFP阴性和无肝硬变患者远期疗效较男性、AFP阳性、有肝硬变者为佳。保留正常肝组织越多手术死亡率越低,远期随访生存率越高。左半肝切除优于右半肝。结节型较巨块型与结节融合型疗效差。术前术后配合喜混化疗可降低死亡率,提高切除术和术后生存率。根据随访分析,作者提出对原发性肝癌手术切除适应症的看法。
This article collected 195 cases of surgical resection of primary liver cancer, follow-up 1, 3, 5, 10-year survival rates were 60.2%, 28.7%, 22.9%, 12.5%. The resection rate was 34%. Sixteen patients died within 20 days after surgery (8.2%). The long-term efficacy of female AFP-negative and non-cirrhotic patients is better than that of men, AFP-positive, and cirrhosis. The higher the normal liver tissue was, the lower the morbidity was and the higher the survival rate was in long-term follow-up. The left hemihepatectomy was better than the right hemi liver. Nodules are more effective than giant blocks and nodules. Preoperative and postoperative combined with chemotherapy can reduce mortality, improve resection and postoperative survival. According to the follow-up analysis, the authors put forward the view of surgical resection indication for primary liver cancer.